Literature DB >> 10810219

Evaluation of seprafilm and amniotic membrane as adhesion prophylaxis in mesh repair of abdominal wall hernia in rats.

A Szabo1, M Haj, I Waxsman, A Eitan.   

Abstract

INTRODUCTION: Adhesion formation following abdominal wall hernia repair with prosthetic mesh may lead to intestinal obstruction and enterocutaneous fistula. Physical barriers, namely, human amniotic membrane (HAM) or Seprafilm (Genzyme, Cambridge, Mass., USA), a bio-absorbable, translucent membrane composed of carboxymethylcellulose and hyaluronic acid, have been reported to prevent postsurgical intra-abdominal adhesions.
OBJECTIVE: Evaluating the effect of HAM and Seprafilm in preventing adhesion formation in the rat model of ventral hernia repair with polypropylene mesh (PPM).
MATERIAL AND METHODS: Sixty female Sprague-Dawley rats were divided into three groups. A full-thickness abdominal wall defect was created in each animal. Control animals had the PPM sutured into the defect, whereas in the other two groups, either HAM or Seprafilm were laid over the abdominal viscera before the repair with PPM. Half of the animals in each group were sacrificed on the 21st postoperative day. The remaining rats of the same group were re-operated on the 42nd day for investigation and measurement of the adhesion area in relation to the graft area.
RESULTS: Direct mesh repair showed 52.8 and 56% area adhesion formation 3 and 6 weeks postoperatively, respectively. The HAM barrier covered with mesh repair demonstrated 0 and 0.96% area adhesion formation, and the Seprafilm-covered mesh repair showed 0 and 0% area adhesion formation 3 and 6 weeks postoperatively, respectively. Uncovered mesh showed a significantly larger adhesion area than both covered mesh (p = 0.001 and 0.001). Both HAM and Seprafilm were equally effective in preventing postoperative adhesions.
CONCLUSIONS: HAM and Seprafilm proved to be an effective antiadhesive barrier in PPM repair of abdominal wall hernia. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810219     DOI: 10.1159/000008751

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  17 in total

1.  Combined therapy of allantoin, metronidazole, dexamethasone on the prevention of intra-abdominal adhesion in dogs and its quantitative analysis.

Authors:  Xiao-Chen Wang; Chang-Qing Gui; Qing-Shan Zheng
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

2.  Omentum prevents intestinal adhesions to mesh graft in abdominal infections and serosal defects.

Authors:  B Karabulut; K Sönmez; Z Türkyilmaz; B Demiroğullari; R Karabulut; C Sezer; N Sultan; A C Başaklar; N Kale
Journal:  Surg Endosc       Date:  2006-05-11       Impact factor: 4.584

3.  Dried human amniotic membrane as an antiadherent layer for intraperitoneal placing of polypropylene mesh in rats.

Authors:  Franco Pomilio Di Loreto; Andrés Mangione; Ezequiel Palmisano; Juan Ignacio Cerda; María José Dominguez; Guillermo Ponce; Marianela Bernaus; Silvina Gaffuri; Guillermo Torresi; Sergio Bianco
Journal:  Surg Endosc       Date:  2013-02-08       Impact factor: 4.584

Review 4.  Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility.

Authors:  Jan Bosteels; Steven Weyers; Thomas M D'Hooghe; Helen Torrance; Frank J Broekmans; Su Jen Chua; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2017-11-27

5.  Human vital amniotic membrane reduces adhesions in experimental intraperitoneal onlay mesh repair.

Authors:  A H Petter-Puchner; R H Fortelny; K Mika; S Hennerbichler; H Redl; C Gabriel
Journal:  Surg Endosc       Date:  2010-12-10       Impact factor: 4.584

6.  Effects of amniotic membrane on the healing of normal and high-risk colonic anastomoses in rats.

Authors:  Mehmet Uludag; Bulent Citgez; Ozay Ozkaya; Gurkan Yetkin; Omer Ozcan; Nedim Polat; Adnan Isgor
Journal:  Int J Colorectal Dis       Date:  2009-03-12       Impact factor: 2.571

7.  Covering the colon anastomoses with amniotic membrane prevents the negative effects of early intraperitoneal 5-FU administration on anastomotic healing.

Authors:  Mehmet Uludag; Kursat Ozdilli; Bulent Citgez; Gurkan Yetkin; Osman M Ipcioglu; Omer Ozcan; Nedim Polat; Abdulcabbar Kartal; Pinar Torun; Adnan Isgor
Journal:  Int J Colorectal Dis       Date:  2009-10-29       Impact factor: 2.571

8.  [PAUL procedure. A new biocompatible concept for the therapy of congenital abdominal wall defects].

Authors:  T Meyer; A Seifert; B Meyer; K Ulrichs; C-T Germer
Journal:  Chirurg       Date:  2010-03       Impact factor: 0.955

9.  Evaluation of a new composite prosthesis (PL-PU99) for the repair of abdominal wall defects in terms of behavior at the peritoneal interface.

Authors:  Juan M Bellón; Alberto García-Carranza; Francisca Jurado; Natalio García-Honduvilla; Antonio Carrera-San Martín; Julia Buján
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

10.  A new biocompatible material (Lyoplant) for the therapy of congenital abdominal wall defects: first experimental results in rats.

Authors:  Thomas Meyer; Karin Schwarz; Karin Ulrichs; Burkhard Höcht
Journal:  Pediatr Surg Int       Date:  2006-03-04       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.